PHARMADRIES: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
PHARMADRIES
Largest movements
- Receivables within one year -€161,110
down €161,110 (-38.9%), from €414,198 to €253,088
of which Other amounts receivable: -€157,962
- Cash -€117,242
down €117,242 (-62.0%), from €189,145 to €71,902
mainly Other debts (-€318,013) and Debts after one year (-€19,531)
- Stocks and contracts -€28,086
down €28,086 (-19.0%), from €147,874 to €119,788
- Other debts -€318,013
no longer reported in 2025 (was €318,013)
- Profit (loss) carried forward +€59,519
up €59,519 (+382.1%), from €15,578 to €75,097
- Debts after one year -€19,531
down €19,531 (-8.4%), from €231,806 to €212,276
- Trade debts -€14,539
down €14,539 (-12.5%), from €116,329 to €101,790
- Tax, wage and social debts -€11,726
down €11,726 (-63.5%), from €18,459 to €6,732
of which Remuneration and social security: -€7,893
- Gross operating margin -€18,051
down €18,051 (-7.1%), from €253,094 to €235,043
- Staff costs +€8,608
up €8,608 (+7.5%), from €114,315 to €122,923
- Depreciation -€4,796
down €4,796 (-19.4%), from €24,668 to €19,872
- Taxes -€4,127
down €4,127 (-16.0%), from €25,768 to €21,641
- Financial charges -€3,614
down €3,614 (-38.6%), from €9,375 to €5,761
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €967,678 | €662,425 | -€305,253 | -31.5% |
| Fixed assets | 21/28 | €214,544 | €212,002 | -€2,543 | -1.2% |
| Tangible fixed assets | 22/27 | €214,544 | €212,002 | -€2,543 | -1.2% |
| Land and buildings | 22 | €188,116 | €190,314 | +€2,198 | +1.2% |
| Plant, machinery and equipment | 23 | €21,517 | €15,933 | -€5,585 | -26.0% |
| Furniture and vehicles | 24 | €4,910 | €5,755 | +€844 | +17.2% |
| Current assets | 29/58 | €753,134 | €450,424 | -€302,710 | -40.2% |
| Stocks and contracts in progress | 3 | €147,874 | €119,788 | -€28,086 | -19.0% |
| Stocks | 30/36 | €147,874 | €119,788 | -€28,086 | -19.0% |
| Amounts receivable within one year | 40/41 | €414,198 | €253,088 | -€161,110 | -38.9% |
| Trade receivables | 40 | €84,658 | €81,509 | -€3,148 | -3.7% |
| Other amounts receivable | 41 | €329,540 | €171,578 | -€157,962 | -47.9% |
| Current investments | 50/53 | €1,917 | €1,917 | = | 0.0% |
| Cash at bank and in hand | 54/58 | €189,145 | €71,902 | -€117,242 | -62.0% |
| Deferred charges and accrued income | 490/1 | - | €3,728 | +€3,728 | |
| Total equity and liabilities | 10/49 | €967,678 | €662,425 | -€305,253 | -31.5% |
| Equity | 10/15 | €262,578 | €322,097 | +€59,519 | +22.7% |
| Contributions | 10/11 | €120,000 | €120,000 | = | 0.0% |
| Capital | 10 | - | €120,000 | +€120,000 | |
| Issued capital | 100 | - | €120,000 | +€120,000 | |
| Reserves | 13 | €127,000 | €127,000 | = | 0.0% |
| Non-distributable reserves | 130/1 | €12,000 | €12,000 | = | 0.0% |
| Legal reserve | 130 | - | €12,000 | +€12,000 | |
| Reserves not available under the articles | 1311 | €12,000 | - | -€12,000 | |
| Distributable reserves | 133 | €115,000 | €115,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €15,578 | €75,097 | +€59,519 | +382.1% |
| Amounts payable | 17/49 | €705,100 | €340,328 | -€364,771 | -51.7% |
| Amounts payable after more than one year | 17 | €231,806 | €212,276 | -€19,531 | -8.4% |
| Financial debts | 170/4 | €231,806 | €212,276 | -€19,531 | -8.4% |
| Amounts payable within one year | 42/48 | €472,935 | €128,053 | -€344,883 | -72.9% |
| Current portion of amounts payable after more than one year | 42 | €20,135 | €19,531 | -€605 | -3.0% |
| Trade debts | 44 | €116,329 | €101,790 | -€14,539 | -12.5% |
| Suppliers | 440/4 | €116,329 | €101,790 | -€14,539 | -12.5% |
| Taxes, remuneration and social security | 45 | €18,459 | €6,732 | -€11,726 | -63.5% |
| Taxes | 450/3 | €3,833 | - | -€3,833 | |
| Remuneration and social security | 454/9 | €14,625 | €6,732 | -€7,893 | -54.0% |
| Other amounts payable | 47/48 | €318,013 | - | -€318,013 | |
| Accrued charges and deferred income | 492/3 | €358 | - | -€358 | |
| Remuneration, social security and pensions | 62 | €114,315 | €122,923 | +€8,608 | +7.5% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €24,668 | €19,872 | -€4,796 | -19.4% |
| Other operating charges | 640/8 | €5,364 | €5,329 | -€35 | -0.6% |
| Gross operating margin | 9900 | €253,094 | €235,043 | -€18,051 | -7.1% |
| Operating profit (loss) | 9901 | €108,748 | €86,920 | -€21,828 | -20.1% |
| Financial income | 75/76B | €146 | - | -€146 | |
| Recurring financial income | 75 | €146 | - | -€146 | |
| Financial charges | 65/66B | €9,375 | €5,761 | -€3,614 | -38.6% |
| Recurring financial charges | 65 | €9,375 | €5,761 | -€3,614 | -38.6% |
| Profit (loss) for the period before taxes | 9903 | €99,520 | €81,159 | -€18,360 | -18.4% |
| Income taxes | 67/77 | €25,768 | €21,641 | -€4,127 | -16.0% |
| Profit (loss) for the period | 9904 | €73,752 | €59,519 | -€14,233 | -19.3% |
| Profit (loss) for the period to be appropriated | 9905 | €73,752 | €59,519 | -€14,233 | -19.3% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 5 October 2026 via checked.be.